Wanbury's Patalganga facility received GMP certification from Brazil's ANVISA, following a review of a US FDA inspection report. This complements approval for their Tanuku site, ensuring both API manufacturing locations meet Brazilian standards.

• ANVISA approval validates facility compliance.
• Both Wanbury API sites are now ANVISA compliant.
• Wanbury operates in global API & formulation markets.